Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

PEG10 is associated with treatment-induced neuroendocrine prostate cancer.

Kim S, Thaper D, Bidnur S, Toren P, Akamatsu S, Bishop JL, Colins C, Vahid S, Zoubeidi A.

J Mol Endocrinol. 2019 Jul 1;63(1):39-49. doi: 10.1530/JME-18-0226.

PMID:
31013476
2.

Receptor from Streptococcus pyogenes as a potential antidote against sperm immobilization factor-induced sperm impairment and infertility.

Thaper D, Rahi DK, Prabha V.

Microb Pathog. 2019 Mar;128:55-62. doi: 10.1016/j.micpath.2018.12.041. Epub 2018 Dec 21.

PMID:
30583018
3.

Amelioration of sperm immobilisation factor-induced infertility by bacterial antigenic determinants cross-reacting with spermatozoa.

Thaper D, Rahi DK, Prabha V.

Reprod Fertil Dev. 2019 Mar;31(3):602-612. doi: 10.1071/RD18300.

PMID:
30517837
4.

Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.

Thaper D, Vahid S, Kaur R, Kumar S, Nouruzi S, Bishop JL, Johansson M, Zoubeidi A.

Sci Rep. 2018 Nov 23;8(1):17307. doi: 10.1038/s41598-018-35612-z.

5.

Pseudomonas aeruginosa: A risk factor for fertility in male mice.

Rana K, Thaper D, Vander H, Prabha V.

Reprod Biol. 2018 Dec;18(4):450-455. doi: 10.1016/j.repbio.2018.08.002. Epub 2018 Sep 1.

PMID:
30181055
6.

Molecular mimicry: An explanation for autoimmune diseases and infertility.

Thaper D, Prabha V.

Scand J Immunol. 2018 Jun 23:e12697. doi: 10.1111/sji.12697. [Epub ahead of print] Review.

7.

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.

Peacock JW, Takeuchi A, Hayashi N, Liu L, Tam KJ, Al Nakouzi N, Khazamipour N, Tombe T, Dejima T, Lee KC, Shiota M, Thaper D, Lee WC, Hui DH, Kuruma H, Ivanova L, Yenki P, Jiao IZ, Khosravi S, Mui AL, Fazli L, Zoubeidi A, Daugaard M, Gleave ME, Ong CJ.

EMBO Mol Med. 2018 Feb;10(2):219-238. doi: 10.15252/emmm.201707689.

8.

Targeting Lyn regulates Snail family shuttling and inhibits metastasis.

Thaper D, Vahid S, Nip KM, Moskalev I, Shan X, Frees S, Roberts ME, Ketola K, Harder KW, Gregory-Evans C, Bishop JL, Zoubeidi A.

Oncogene. 2017 Jul 13;36(28):3964-3975. doi: 10.1038/onc.2017.5. Epub 2017 Mar 13.

PMID:
28288135
9.

Is there a role for Serratia marcescens in male infertility: An experimental study?

Rana K, Thaper D, Prabha V.

Microb Pathog. 2017 Apr;105:13-18. doi: 10.1016/j.micpath.2017.01.061. Epub 2017 Feb 1.

PMID:
28161359
10.

Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer.

Vahid S, Thaper D, Zoubeidi A.

Recent Pat Anticancer Drug Discov. 2017;12(1):35-47. doi: 10.2174/1574892811666161102125252. Review.

PMID:
27809750
11.

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.

Bishop JL, Thaper D, Vahid S, Davies A, Ketola K, Kuruma H, Jama R, Nip KM, Angeles A, Johnson F, Wyatt AW, Fazli L, Gleave ME, Lin D, Rubin MA, Collins CC, Wang Y, Beltran H, Zoubeidi A.

Cancer Discov. 2017 Jan;7(1):54-71. doi: 10.1158/2159-8290.CD-15-1263. Epub 2016 Oct 26.

12.

Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.

Vahid S, Thaper D, Gibson KF, Bishop JL, Zoubeidi A.

Sci Rep. 2016 Aug 24;6:31842. doi: 10.1038/srep31842.

13.

Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer.

Zardan A, Nip KM, Thaper D, Toren P, Vahid S, Beraldi E, Fazli L, Lamoureux F, Gust KM, Cox ME, Bishop JL, Zoubeidi A.

Oncogenesis. 2014 Aug 18;3:e115. doi: 10.1038/oncsis.2014.30.

14.

Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.

Cordonnier T, Bishop JL, Shiota M, Nip KM, Thaper D, Vahid S, Heroux D, Gleave M, Zoubeidi A.

Int J Cancer. 2015 Mar 15;136(6):E496-507. doi: 10.1002/ijc.29122. Epub 2014 Dec 4.

15.

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.

Bishop JL, Thaper D, Zoubeidi A.

Cancers (Basel). 2014 Apr 9;6(2):829-59. doi: 10.3390/cancers6020829.

16.

Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth.

Takeuchi A, Shiota M, Beraldi E, Thaper D, Takahara K, Ibuki N, Pollak M, Cox ME, Naito S, Gleave ME, Zoubeidi A.

Mol Cell Endocrinol. 2014 Mar 25;384(1-2):117-25. doi: 10.1016/j.mce.2014.01.012. Epub 2014 Feb 1.

PMID:
24491388
17.

Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo.

Thomas C, Lamoureux F, Crafter C, Davies BR, Beraldi E, Fazli L, Kim S, Thaper D, Gleave ME, Zoubeidi A.

Mol Cancer Ther. 2013 Nov;12(11):2342-55. doi: 10.1158/1535-7163.MCT-13-0032. Epub 2013 Aug 21.

Supplemental Content

Loading ...
Support Center